Prognostic factors in limited (T1-2, N0-1) oropharyngeal carcinoma treated with surgery ± adjuvant therapy

Head and Neck

Volumn 35, Issue 12, 2013, Pages 1752-1758

  Psychogios, Georgios ^a   Mantsopoulos, Konstantinos ^a   Agaimy, Abbas ^a   Koch, Michael ^a   Zenk, Johannes ^a   Waldfahrer, Frank ^a   Iro, Heinrich ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

HPV; oropharyngeal cancer; prognostic factors; surgery; tumor depth

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMORADIOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; DISEASE SPECIFIC SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; TREATMENT OUTCOME;

HPV; OROPHARYNGEAL CANCER; PROGNOSTIC FACTORS; SURGERY; TUMOR DEPTH;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CHEMORADIOTHERAPY; CISPLATIN; DISEASE-FREE SURVIVAL; ELECTROCOAGULATION; FEMALE; FOLLOW-UP STUDIES; HUMAN PAPILLOMAVIRUS 16; HUMANS; LASER THERAPY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NECK DISSECTION; OROPHARYNGEAL NEOPLASMS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURGICAL FLAPS;

EID: 84887992089     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23229     Document Type: Article

References (43)

1. Parsons JT, Mendenhall WM, Stringer SP, et al. Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or both. Cancer 2002; 94: 2967-2980.
2. Allal AS, Nicoucar K, Mach N, Dulguerov P,. Quality of life in patients with oropharynx carcinomas: assessment after accelerated radiotherapy with or without chemotherapy versus radical surgery and postoperative radiotherapy. Head Neck 2003; 25: 833-839; discussion 839-840.
3. Mowry SE, Ho A, Lotempio MM, Sadeghi A, Blackwell KE, Wang MB,. Quality of life in advanced oropharyngeal carcinoma after chemoradiation versus surgery and radiation. Laryngoscope 2006; 116: 1589-1593.
4. Ihloff AS, Petersen C, Hoffmann M, Knecht R, Tribius S,. Human papilloma virus in locally advanced stage III/IV squamous cell cancer of the oropharynx and impact on choice of therapy. Oral Oncol 2010; 46: 705-711.
5. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML,. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008; 26: 612-619.
6. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363: 24-35.
7. Chen AY, Schrag N, Hao Y, Stewart A, Ward E,. Changes in treatment of advanced oropharyngeal cancer, 1985-2001. Laryngoscope 2007; 117: 16-21.
8. Haigentz M Jr, Silver CE, Corry J, et al. Current trends in initial management of oropharyngeal cancer: the declining use of open surgery. Eur Arch Otorhinolaryngol 2009; 266: 1845-1855.
9. Cohan DM, Popat S, Kaplan SE, Riqual N, Loree T, Hicks WL Jr,. Oropharyngeal cancer: current understanding and management. Curr Opin Otolaryngol Head Neck Surg 2009; 17: 88-94.
10. Pederson AW, Haraf DJ, Witt ME, et al. Chemoradiotherapy for locoregionally advanced squamous cell carcinoma of the base of tongue. Head Neck 2010; 32: 1519-1527.
11. Eisbruch A, Harris J, Garden AS, et al. Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22). Int J Radiat Oncol Biol Phys 2010; 76: 1333-1338.
12. Kreeft AM, van der Molen L, Hilgers FJ, Balm AJ,. Speech and swallowing after surgical treatment of advanced oral and oropharyngeal carcinoma: a systematic review of the literature. Eur Arch Otorhinolaryngol 2009; 266: 1687-1698.
13. Weinstein GS, Quon H, O'Malley BW Jr, Kim GG, Cohen MA,. Selective neck dissection and deintensified postoperative radiation and chemotherapy for oropharyngeal cancer: a subset analysis of the University of Pennsylvania transoral robotic surgery trial. Laryngoscope 2010; 120: 1749-1755.
14. Bozec A, Poissonnet G, Chamorey E, et al. Quality of life after oral and oropharyngeal reconstruction with a radial forearm free flap: prospective study. J Otolaryngol Head Neck Surg 2009; 38: 401-408.
15. Walvekar RR, Li RJ, Gooding WE, et al. Role of surgery in limited (T1-2, N0-1) cancers of the oropharynx. Laryngoscope 2008; 118: 2129-2134.
16. Selek U, Garden AS, Morrison WH, El-Naggar AK, Rosenthal DI, Ang KK,. Radiation therapy for early-stage carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys 2004; 59: 743-751.
17. Moncrieff M, Sandilla J, Clark J, et al. Outcomes of primary surgical treatment of T1 and T2 carcinomas of the oropharynx. Laryngoscope 2009; 119: 307-311.
18. Mantsopoulos K, Psychogios G, Waldfahrer F, Zenk J, Iro H,. Surgical treatment of locally limited tonsillar cancer. Surg Oncol 2012; 21: e13-e16.
19. Shin HA, Lim YC, Jeong HM, Choi EC,. Role of primary surgery for early-stage (T1-2N0) squamous cell carcinoma of the oropharynx. Oral Oncol 2009; 45: 1063-1066.
20. Lim YC, Hong HJ, Baek SJ, et al. Combined surgery and postoperative radiotherapy for oropharyngeal squamous cell carcinoma in Korea: analysis of 110 cases. Int J Oral Maxillofac Surg 2008; 37: 1099-1105.
21. Charbonneau N, Gélinas M, del Vecchio P, et al. Primary radiotherapy for tonsillar carcinoma: a good alternative to a surgical approach. J Otolaryngol 2006; 35: 227-234.
22. American Joint Committee on Cancer (AJCC) Cancer Staging Manual, 7th edition. In:, Edge SC, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. New York: Springer-Verlag; 2010.
23. Ukpo OC, Flanagan JJ, Ma XJ, Luo Y, Thorstad WL, Lewis JS Jr,. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma. Am J Surg Pathol 2011; 35: 1343-1350.
24. O'Hara J, MacKenzie K,. Surgical versus non-surgical management of early stage oropharyngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 2011; 268: 437-442.
25. Iro H, Mantsopoulos K, Zenk J, Waldfahrer F, Psychogios G,. Results of transoral laser resection in T1-2 oropharyngeal, hypopharyngeal and laryngeal carcinomas. [Article in German] Laryngorhinootologie 2011; 90: 481-485.
26. Karatzanis AD, Psychogios G, Waldfahrer F, Zenk J, Velegrakis GA, Iro H,. Surgical management of T1 oropharyngeal carcinoma. Head Neck 2011; 34: 1277-1282.
27. Nguyen NP, Ly BH, Betz M, Vinh-Hung V,. Importance of age as a prognostic factor for tonsillar carcinoma. Ann Surg Oncol 2010; 17: 2570-2577.
28. Bessell A, Glenny AM, Furness S, et al. Interventions for the treatment of oral and oropharyngeal cancers: surgical treatment. Cochrane Database Syst Rev 2011: CD006205.
29. Karatzanis AD, Psychogios G, Mantsopoulos K, et al. Management of advanced carcinoma of the base of tongue. J Surg Oncol 2012; 106: 713-718.
30. Röösli C, Tschudi DC, Studer G, Braun J, Stoeckli SJ,. Outcome of patients after treatment for a squamous cell carcinoma of the oropharynx. Laryngoscope 2009; 119: 534-540.
31. Psychogios G, Mantsopoulos K, Kuenzel J, et al. Primary surgical treatment of T2 oropharyngeal carcinoma. J Surg Oncol 2012; 105: 719-723.
32. Po Wing Yuen A, Lam KY, Lam LK, et al. Prognostic factors of clinically stage I and II oral tongue carcinoma-a comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, Martinez-Gimeno score, and pathologic features. Head Neck 2002; 24: 513-520.
33. Huang SH, Hwang D, Lockwood G, Goldstein DP, O'Sullivan B,. Predictive value of tumor thickness for cervical lymph-node involvement in squamous cell carcinoma of the oral cavity: a meta-analysis of reported studies. Cancer 2009; 115: 1489-1497.
34. Pentenero M, Gandolfo S, Carrozzo M,. Importance of tumor thickness and depth of invasion in nodal involvement and prognosis of oral squamous cell carcinoma: a review of the literature. Head Neck 2005; 27: 1080-1091.
35. Fukano H, Matsuura H, Hasegawa Y, Nakamura S,. Depth of invasion as a predictive factor for cervical lymph node metastasis in tongue carcinoma. Head Neck 1997; 19: 205-210.
36. Ihloff AS, Petersen C, Hoffmann M, Knecht R, Tribius S,. Human papilloma virus in locally advanced stage III/IV squamous cell cancer of the oropharynx and impact on choice of therapy. Oral Oncol 2010; 46: 705-711.
37. Shoushtari A, Meeneghan M, Sheng K, et al. Intensity-modulated radiotherapy outcomes for oropharyngeal squamous cell carcinoma patients stratified by p16 status. Cancer 2010; 116: 2645-2654.
38. Lassen P, Eriksen JG, Hamilton-Dutoit S, Tramm T, Alsner J, Overgaard J,. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol 2009; 27: 1992-1998.
39. Ambrosch P, Kron M, Pradier O, Steiner W,. Efficacy of selective neck dissection: a review of 503 cases of elective and therapeutic treatment of the neck in squamous cell carcinoma of the upper aerodigestive tract. Otolaryngol Head Neck Surg 2001; 124: 180-187.
40. Strojan P, Ferlito A, Langendijk JA, Silver CE,. Indications for radiotherapy after neck dissection. Head Neck 2012; 34: 113-119.
41. Moergel M, Jahn-Eimermacher A, Krummenauer F, et al. Effectiveness of adjuvant radiotherapy in patients with oropharyngeal and floor of mouth squamous cell carcinoma and concomitant histological verification of singular ipsilateral cervical lymph node metastasis (pN1-state)-a prospective multicenter randomized controlled clinical trial using a comprehensive cohort design. Trials 2009; 10: 118.
42. Rodrigo JP, Shah JP, Silver CE, et al. Management of the clinically negative neck in early-stage head and neck cancers after transoral resection. Head Neck 2011; 33: 1210-1219.
43. Psychogios G, Mantsopoulos K, Bohr C, et al. Incidence of occult cervical metastasis in head and neck carcinomas: Development over time. J Surg Oncol 2012; doi: 10.1002/jso.23221. [Epub ahead of print].